CI
CVI Investments, Inc. disclosed a 7.9% stake in OTLK
CVI Investments, Inc. reported owning 7.9% of Outlook Therapeutics, Inc. (OTLK) (21,000,000 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G